Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2008-05-27
2008-05-27
Habte, Kahsay T (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S105000
Reexamination Certificate
active
11241632
ABSTRACT:
Compounds of the formula I:or a pharmaceutically acceptable salt, solvate or prodrug thereof, wherein k, m, n, p, q, X, Y, Z, Ar, R1, R2, R3and R4are as defined herein. Also provided are methods for preparing, compositions comprising, and methods for using compounds of formula I.
REFERENCES:
patent: 5321025 (1994-06-01), Bruneau
patent: 5475009 (1995-12-01), Chernesky et al.
patent: 5691362 (1997-11-01), McCormick et al.
patent: 6867204 (2005-03-01), Berger et al.
patent: 0 432 893 (1991-06-01), None
patent: 0 570 112 (1993-11-01), None
patent: 0 462 813 (1995-10-01), None
patent: 0 462 830 (1995-10-01), None
patent: 0 407 137 (1996-05-01), None
patent: 2000 327663 (2000-11-01), None
patent: WO 92/16524 (1992-10-01), None
patent: WO 94/05281 (1994-03-01), None
patent: WO 94/26739 (1994-11-01), None
patent: WO 95/30668 (1995-11-01), None
patent: WO 98/00412 (1998-01-01), None
patent: WO 98/50372 (1998-11-01), None
patent: WO 01/57003 (2001-08-01), None
patent: WO 02/072049 (2002-09-01), None
patent: WO 02/085868 (2002-10-01), None
Rusell MG and Dias R. (Curr. Top. Med. Chem, Jun. 2002; 2(6):643-54).
Sethofer Steven
Zhang Li
Zhao Shu-Hai
Habte Kahsay T
Hall Robert C.
Roche Palo Alto LLC
LandOfFree
Benzoxazine and quinoxaline derivatives and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzoxazine and quinoxaline derivatives and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzoxazine and quinoxaline derivatives and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3948304